U.S. Wireless Telecom Stock News

NYSE:ADM
NYSE:ADMFood

How Investors Are Reacting To Archer-Daniels-Midland (ADM) Doubling Down On Ethics And Farmer Resilience

Earlier in March 2026, ADM was again named one of the World’s Most Ethical Companies and ADM Cares committed US$500,000 to a new American Farmland Trust partnership supporting farmer resilience, succession planning, and access to resources across six Midwestern states. Together with the upcoming Future Food-Tech presentation by its Sustainable Materials and Strategic Initiatives president, these moves highlight ADM’s emphasis on ethics, farmer well-being, and long-term agricultural...
NasdaqGS:AGNC
NasdaqGS:AGNCMortgage REITs

Do AGNC’s Reaffirmed Dividends Hint at a Durable Income Model or Heightened Risk Balance for AGNC (AGNC)?

AGNC Investment Corp. previously announced that its Board of Directors declared a US$0.12 per-share cash dividend for March 2026, payable on April 10, 2026 to common stockholders of record as of March 31, 2026. The simultaneous declaration of quarterly dividends across multiple preferred series, with varying fixed-to-floating and fixed reset structures, underscores AGNC’s emphasis on maintaining consistent income for both common and preferred shareholders. We’ll now examine how reaffirming...
NasdaqGS:GFS
NasdaqGS:GFSSemiconductor

GlobalFoundries Targets AI Data Centers With Silicon Photonics Push

GlobalFoundries (NasdaqGS:GFS) is expanding into silicon photonics, working with Flexcompute to link photonic device design tools directly to its manufacturing stack. The collaboration focuses on optical interconnects for AI data centers, aiming to streamline the path from simulation to fabrication. This move targets a growing market in data center optics while seeking to lower design and integration hurdles for customers. GLOBALFOUNDRIES, trading at $42.47, is drawing attention in advanced...
NasdaqGS:DFTX
NasdaqGS:DFTXPharmaceuticals

Is It Too Late To Consider Definium Therapeutics (DFTX) After A 163% One Year Surge?

Considering whether Definium Therapeutics at around US$17.64 still offers value, or if most of the opportunity is already priced in. The stock has seen a 5.3% decline over the last 7 days, but sits on gains of 12.0% over 30 days, 29.3% year to date and 163.3% over 1 year, with a very large 3 year return that is more than 5x, although the 5 year return is a 54.3% decline. Recent market attention has been shaped by broader interest in high growth pharmaceutical and biotech names, where...
NYSE:CI
NYSE:CIHealthcare

Did Bernstein’s PBM-Focused Upgrade Just Shift Cigna Group’s (CI) Investment Narrative?

On March 12, 2026, analysts at Bernstein upgraded The Cigna Group to “Outperform,” citing the impact of PBM reform, an FTC settlement, and changes to the company’s pharmacy benefit model on investor perception. This shift in analyst stance highlights how regulatory outcomes and PBM model adjustments can influence expectations around Cigna’s health services business mix and risk profile. Next, we’ll explore how Bernstein’s upgrade, rooted in PBM reform and regulatory developments, may reshape...
NasdaqGS:BRKR
NasdaqGS:BRKRLife Sciences

Artisan Partners Backs Bruker As Acquisitions And Pipeline Face Market Headwinds

Artisan Partners has taken a new small cap position in Bruker (NasdaqGS:BRKR), citing confidence in the company’s acquisitions and product pipeline. The investment thesis points to anticipated easing of short term market headwinds as a support for future profit growth. Bruker’s share price stands at $34.03 after a period of pressure, with the stock down 7.6% over the past week and 6.8% over the past month. The drawdown is more extended over longer periods, with a 29.3% decline year to date...
NasdaqGS:CAPR
NasdaqGS:CAPRBiotechs

Why Capricor Therapeutics (CAPR) Is Down 8.0% After FDA Resumes Deramiocel Review And Phase 3 Update

Earlier this month, Capricor Therapeutics reported Q4 2025 and full-year results showing a wider net loss of US$30.17 million for the quarter and US$105.04 million for the year, alongside continued investment in its Duchenne muscular dystrophy pipeline. A key development was new Phase 3 HOPE-3 data and the FDA’s decision to resume review of Deramiocel’s Biologics License Application, setting an August 22, 2026 action date for a potential decision on treating Duchenne cardiomyopathy. With the...
NasdaqGS:TTMI
NasdaqGS:TTMIElectronic

A Look At TTM Technologies (TTMI) Valuation After A Strong Year Of Share Price Momentum

Why TTM Technologies (TTMI) Is On Investors’ Radar Today TTM Technologies (TTMI) is drawing attention after recent share price moves, with the stock showing varied short term returns and a stronger performance over the past year that may prompt closer portfolio review. See our latest analysis for TTM Technologies. The latest share price of $95.31 comes after a 42.06% 90 day share price return and a very large 1 year total shareholder return. Together, these indicate strong recent momentum...
NasdaqGS:HIMX
NasdaqGS:HIMXSemiconductor

Himax Technologies Shifts Toward AI Modules And Automotive Display Growth

Himax Technologies (NasdaqGS:HIMX) highlighted new AI powered modules and automotive display ICs at Embedded World 2026. The company showcased WiseEye, WiseGuard and PalmVein ultralow power AI solutions for smart home, security, automotive and drone uses. Rumors point to potential collaborations with major tech firms for smart glasses integration and AI data center applications. For you as an investor, this matters because Himax Technologies, long known for display driver ICs, is now...
NasdaqCM:ONDS
NasdaqCM:ONDSCommunications

Has The Recent Surge Left Ondas (ONDS) Looking Mispriced?

If you are trying to figure out whether Ondas at around US$10.83 is still attractively priced, the starting point is understanding what that share price really implies about the business. The stock has shown sharp moves, with a 10.2% return over the last 7 days, 16.3% over 30 days, a small 1.7% decline year to date, and a very large gain over the past year and over the last 3 years. Recent coverage has focused on Ondas as a higher risk, higher return name within the tech space, which helps...
NYSE:PPL
NYSE:PPLElectric Utilities

Assessing PPL’s Valuation After Earnings Update And US$23b Infrastructure Investment Plan

Event driven move in PPL stock PPL (PPL) is back in focus after the company reported 2025 results, issued a 2026 EPS growth forecast, extended its annual EPS growth target through at least 2029, and outlined a US$23b infrastructure investment plan. See our latest analysis for PPL. At a share price of US$38.05, PPL has had a 9.5% 90 day share price return and a 12.2% 1 year total shareholder return, suggesting momentum has been building alongside its latest results and infrastructure plan. If...
NasdaqGS:SANM
NasdaqGS:SANMElectronic

Is It Time To Reassess Sanmina (SANM) After Its Strong Multi Year Share Price Run?

Wondering if Sanmina's share price really reflects its underlying value, or if the recent run in the stock has left mispricing on the table. The stock closed at US$125.03, with returns of 59.8% over 1 year and 118.1% over 3 years, even as the share price has seen a 14.3% drop over 30 days and a 21.5% fall year to date. Recent coverage has focused on Sanmina's role in technology manufacturing and its positioning within the broader electronics supply chain, giving investors more information to...
NYSE:CXT
NYSE:CXTElectronic

Crane NXT Board Shift Brings New Tech Focus To Undervalued Shares

Crane NXT (NYSE:CXT) has appointed technology and manufacturing executive Jeffrey Benck to its Board of Directors. Longtime director James L.L. Tullis will step down from the board after the upcoming Annual Meeting. The board change introduces new industry experience and marks the end of a lengthy period of service by Tullis. For investors tracking Crane NXT, the board shift comes at a time when the share price stands at $41.37, with the stock showing a 21.6% decline over the past 30 days...
NYSE:DHT
NYSE:DHTOil and Gas

The Bull Case For DHT Holdings (DHT) Could Change Following Fully Funded VLCC Fleet Expansion - Learn Why

DHT Holdings, Inc. has already taken delivery of its second VLCC newbuilding, the DHT Addax, from Hanwha Ocean Co. Ltd., with the fully funded vessel now operating in the spot market as part of a four-ship program scheduled for completion in the first half of 2026. This incremental capacity, arriving in a short time frame and fully financed, directly enhances DHT’s service offering and potential earnings power without stretching the balance sheet. We’ll now examine how this fully funded VLCC...
NasdaqGS:GSHD
NasdaqGS:GSHDInsurance

Is Goosehead (GSHD) Using ESOP Shares to Sharpen Alignment or Dilute Its Investment Story?

In March 2026, Goosehead Insurance, Inc. filed a shelf registration for up to US$66.65 million, covering 1,510,000 common shares in an employee stock ownership plan (ESOP)-related offering. This ESOP-linked shelf registration highlights Goosehead’s emphasis on employee ownership, which can influence incentives, capital structure, and longer-term business alignment. We’ll now examine how this ESOP-related shelf registration could influence Goosehead Insurance’s investment narrative and its...
NYSE:MAIN
NYSE:MAINCapital Markets

How Main Street Capital’s US$61.5 Million Steel Deal Could Shape MAIN’s Risk Reward Profile

Main Street Capital recently completed a US$61.5 million portfolio investment to support the minority recapitalization of a specialized structural steel fabricator, combining first-lien senior secured term debt, a direct minority equity stake, and a revolving credit facility for future initiatives and working capital. Management also reported record return on equity and growth in net asset value for the latest quarter, underscoring how its blended debt-and-equity approach is shaping the...
NYSE:NOG
NYSE:NOGOil and Gas

A Look At Northern Oil And Gas (NOG) Valuation After Its US$200 Million Follow On Equity Offering

Northern Oil and Gas (NOG) recently completed a follow on equity offering of about US$200 million, issuing 7,207,208 common shares at US$27.75. This event can influence supply, liquidity and investor sentiment. See our latest analysis for Northern Oil and Gas. The follow on offering comes as Northern Oil and Gas trades at US$27.69, with a 90 day share price return of 27.02% and a 5 year total shareholder return of 167.59%. This suggests recent momentum alongside longer term gains, despite a 1...
NasdaqGS:UPST
NasdaqGS:UPSTConsumer Finance

Is Upstart Holdings (UPST) Now Attractive After A 49% One Year Share Price Decline?

Wondering whether Upstart Holdings at around US$25.83 is starting to look like value or still carries more risk than reward? This article walks through the numbers to help you frame that question clearly. The stock has seen sharp swings, with returns of 6.0% decline over 7 days, 15.8% decline over 30 days, a 43.7% decline year to date, and a 49.4% decline over the last year, set against an 83.1% gain over three years and a 77.0% decline over five years. Recently, attention on Upstart has...
NasdaqGS:RGLD
NasdaqGS:RGLDMetals and Mining

A Look At Royal Gold (RGLD) Valuation After Mixed Earnings Dividend Hike And Debt Reduction Plan

Royal Gold (RGLD) is drawing fresh attention after a mixed Q4 2025 earnings report, a raised annual dividend, and management’s plan to eliminate debt by early 2027 ahead of a detailed Investor Day guidance update. See our latest analysis for Royal Gold. After a sharp 15.2% 30 day share price decline and a 12.1% 7 day pullback to around $242.52 following the mixed Q4 results, Royal Gold still sits on a 9.7% year to date share price gain and a 58.2% 1 year total shareholder return. This...
NYSE:ONON
NYSE:ONONLuxury

Is It Time To Reconsider On Holding (ONON) After Recent Share Price Weakness?

If you are wondering whether On Holding's current share price properly reflects its potential, the starting point is understanding how the market is valuing the business today. The stock closed at US$39.05, with returns of a 1% decline over 7 days, a 13.8% decline over 30 days, a 16.8% decline year to date, a 17.0% decline over 1 year, and a 42.7% gain over 3 years, which hints that the market's view of its prospects and risks has shifted over time. Recent news coverage has focused on On...
NasdaqGS:SKWD
NasdaqGS:SKWDInsurance

A Look At Skyward Specialty Insurance Group (SKWD) Valuation After Recent Share Price Pullback

Skyward Specialty Insurance Group (SKWD) has drawn attention after recent trading saw the share price around $42.83, with returns weaker over the past month and the past 3 months compared with the prior 3 years. See our latest analysis for Skyward Specialty Insurance Group. For context, the 1 day share price return of a 4.9% decline and the 90 day share price return of a 17.3% decline sit against a 3 year total shareholder return of 120.1%. This suggests that recent momentum has cooled after...
NYSE:RMD
NYSE:RMDMedical Equipment

ResMed (RMD) Is Down 5.1% After Market Value Slides Despite Solid Fundamentals Has The Bull Case Changed?

In the past week, ResMed’s share price weakness has erased about US$3.30 billion from its market value, leaving the company at roughly US$34.00 billion despite reports that its operating performance and financial condition remain solid. This disconnect between market sentiment and underlying business health raises questions about whether recent trading reflects short-term emotion rather than changes in ResMed’s long-term outlook. Against this backdrop of recent market value erosion despite...
OTCPK:LKNC.Y
OTCPK:LKNC.YHospitality

Is Luckin Coffee (OTCPK:LKNC.Y) Attractive After Recent Share Price Weakness?

If you are wondering whether Luckin Coffee is priced attractively today or running ahead of itself, this breakdown will help you frame what the current share price might be implying. Over the last year, the stock has returned 0.9%, after a 3.7% decline over the past week and a 6.9% decline over the past month from a last close of US$33.92. These moves may have shifted how some investors think about its potential and risk. Recent coverage around Luckin Coffee has focused on its position in...
NYSE:FBIN
NYSE:FBINBuilding

Has Fortune Brands Innovations (FBIN) Fallen Too Far After Recent 12‑Month Share Price Slide

Wondering whether Fortune Brands Innovations at around US$41.35 is starting to look like value or still has more risk priced in? This article walks through the key signals to help you frame that question. The stock has seen a 8.5% decline over the last 7 days, a 19.4% decline over the last 30 days, and is tracking 18.8% lower year to date, with a 33.6% decline over the last 12 months and longer term 24.0% and 41.0% declines over 3 and 5 years respectively. These moves have attracted...